Sexuality, Reproduction & Menopause Continuing Medical Education Program

INSTRUCTIONS

To obtain the 1.5 CME credits for Volume 3, No. 2, October 2005, please follow these instructions.

View Large Image Download to PowerPoint

1.Read the articles listed for CME credit in Sexuality, Reproduction & Menopause.

2.Visit www.asrm.org and click on SRM EXAMS.

3.Print out the exam page.

4.Make a copy of your completed exam before sending to ASRM for your records.

5.Fax completed exam with credit card informationOR

6.Mail completed exam with check to:CME Department/SRM Exam, American Society for Reproductive Medicine1209 Montgomery Highway, Birmingham, AL 35216(205) 978-5000 phone/(205) 978-5005 fax

7.You must achieve at least a 70% passing score. Your corrected exam and documentation will be mailed to you.

8.Your exam must be received by ASRM by December 31, 2005.

Learning Objectives: After reading the designated articles published in Sexuality, Reproduction & Menopause, participants of the Sexuality, Reproduction & Menopause Continuing Medical Education (CME) Program should be able to:

Target Audience: This activity is designed for all physicians with a fundamental interest and knowledge in reproductive medicine and women's health, residents, researchers, clinicians, and educators alike.

Needs Assessment: As healthcare and technology continue to advance, there is a need to provide physicians and other health care professionals with opportunities to access and review information of relevance to their practice in new ways. This activity is designed to allow professionals to study alone at the time of their choice.

Credit/Accreditation Information: The American Society for Reproductive Medicine is accredited by the ACCME to sponsor continuing medical education to physicians.

The American Society for Reproductive Medicine designates the Sexuality, Reproduction & Menopause CME Program for up to 6 (1.5 each issue) category 1 credits toward the AMA Physician's Recognition Award per year. Each physician should claim only those credits that he/she actually spent in the educational activity.

The American Medical Association has determined that non-U.S. licensed physicians who participate in the SRM CME Program are eligible for AMA PRA category 1 credit.

Program participants should answer the questions on the examination answer sheet found at ASRM's website: www.asrm.org. The program is provided at a cost of $5 per examination for members and $10 per examination for non-members. The participant should retain a copy of the examination. A 70% passing score must be achieved in order to earn CME credit. Documentation of satisfactory completion, the correct answers, and a course evaluation form will be mailed within 2 months of receipt of tests.

For additional information, contact the CME Department at the American Society for Reproductive Medicine, 1209 Montgomery Highway, Birmingham, Alabama 35216 (Telephone: 205-978-5000; Fax 205-978-5005; email: asrm@asrm.org). Visit the ASRM website: www.asrm.org.

LESSON 1 

ART and offspring anomalies: How concerned should we be? 

Joe Leigh Simpson, MD

Lesson 1 Objective: To review the evidence that offspring resulting from ART (assisted reproductive technologies) are at increased risk of congenital anomalies.

1.Compared to the general population, ICSI offspring have been associated with an increased risk of:

a.Hypospadias

b.Sex chromosome abnormalities

c.De novo autosomal chromosome abnormalities

d.Imprinting disorders

e.All of the above

2.Beckwith-Wiedemann syndrome, Prader-Willi syndrome, and Angelman syndrome are most often caused by:

a.Disorders of imprinting

b.Chromosomal translocations

c.Sex chromosome abnormalities

d.Autosomal structural chromosomal abnormalities

LESSON 2 

In search of a second contraceptive revolution 

Michael J. K. Harper, PhD, ScD, FIBiol

Lesson 2 Objective: To review the past, present, and future of contraceptive options and development.

1.What US government entity issued a report on family planning technologies in 1982?

a.FDA

b.USAID

c.US Congress Office of Technology Assessment

d.NICHD

2.What steroid did the World Health Organization test clinically to prove that a male hormonal contraceptive was effective?

a.Estrogen

b.Testosterone enanthate

c.Medroxyprogesterone acetate

d.Levonorgestrel

LESSON 3 

“Bioidentical” estrogens: Hope or hype? 

Maida Taylor, MD, MPH

Lesson 3 Objective: To discuss the classification of various estrogens.

1.Native estrogens (or human bioidentical hormones) include all of the following except:

a.Estrone

b.Estradiol

c.Estriol

d.Diethylstilbestrol

2.Diadzein and genistein are examples of:

a.Natural estrogens, ie, mammalian steroid hormones

b.Native estrogens, ie, human bioidentical hormones

c.Phytoestrogens

d.Synthetic estrogens

LESSON 4 

Male infertility: Causes and cures 

Moshe Wald, MD

Lesson 4 Objective: To review the causes and treatment of male infertility.

1.Infertility caused by ejaculatory duct obstruction is usually characterized by all of the following except:

a.Severe oligospermia or azoospermia

b.Low seminal volume

c.Normal size testicles

d.Elevated serum FSH levels

2.The best results in the treatment of immunoinfertility have been reported for:

a.IVF/ICSI

b.Corticosteroids

c.Mechanical methods for sperm-antibody separation

d.Immunomagnetic separation

3.The most commonly identifiable, surgically correctable lesion associated with male factor infertility is:

a.Vasectomy

b.Varicocele

c.Ejaculatory duct obstruction

d.Non-obstructive azoospermia

4.Which of the following genetic disorders is associated with obstructive azoospermia:

a.Klinefelter syndrome

b.Y chromosome microdeletions

c.Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations

d.Kallmann's syndrome

View Large Image Download to PowerPoint